Questions? Chat with the founder on WhatsApp

Chat with the founder on WhatsApp
Arthneeti
HomeRankingsIPOScreenerInstitutions
HomeRankingsIPOScreenerInstitutions
J.G.ChemicalsQ1 FY27Chemicals & Petrochemicals
Home/Stocks/J.G.Chemicals/Q1 FY27

J.G.Chemicals Q1 FY27 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹581P/E: 32.4Market Cap: ₹2.4K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 2

Fundraise

N/A

Order

Yes

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 3
  • →Company expects continued demand momentum throughout the year driven by strong domestic manufacturing and multiple end-user industries (tire, ceramics, pharma, specialty chemicals, agriculture).
  • →Volume growth was in mid-teens in the recent quarter and is expected to sustain with further ramp-up of existing capacities.
  • →New Gujarat (Dahej) plant to be commissioned in November 2026; targets 50-60% utilization in FY27 and 70-80% by FY28, adding 15,000 to 17,000 tons p.a. zinc oxide capacity.
  • →Expanded capacities and capacity improvements expected to drive double-digit volume growth in the near term.
  • →Higher share of value-added and specialized products (like zinc sulphate, ZRA, Lab Pure) will contribute to both volume and value growth.
  • →Non-rubber segments (pharma, ceramics, specialty chemicals) expected to grow faster, increasing overall revenue diversification.
  • →Target EBITDA margins to increase to 13-15% by FY29 with higher value-added product mix.

Margin guidance

Category 2
  • →Company targets volume growth in mid-teens for the current year, supported by capacity ramp-up and new product launches.
  • →EBITDA margins expected to sustain around 11% in FY27 and inch higher in the following years, potentially reaching 13%-15% by FY29 due to increased share of higher value-added products.
  • →New Dahej plant to be commissioned in Q3 FY27; utilization expected to reach 50%-60% in FY27 and 70%-80% in FY28, contributing to margin expansion.
  • →Long-term payback period for new projects like Dahej plant estimated at 3-4 years with ROCE in mid-20% range, indicating strong returns.
  • →Growth to be driven both by rubber & tire segments and increasing contribution from non-rubber sectors such as pharma, specialty chemicals, ceramic, and cosmetics.
  • →New niche products like Lab Pure and ZRA expected to add higher-margin revenue streams over time.
  • →Overall, company remains optimistic on sustainable demand and strong earnings growth ahead.

3 more insights locked — sign up free to unlock

Fundraise plans

  • →The transcript does not explicitly mention any current or future plans for fundraising through debt or equity.
  • →There is discussion about ongoing and planned capital expenditures, such as the new Dahej plant with phased capacity expansion, and rubber recycling project capex.
  • →The management aims for payback periods of 3-4 years on capex and expects returns (ROCE) in the mid-20% range, implying efficient use of internal accruals or financing.
  • →No specific mention was made of raising funds via debt or equity issuance during the call.
  • →The company highlights strong financial positions, operational efficiencies, and existing investor confidence but does not indicate new fundraising efforts at this time.

Order book

Yes
- The transcript does not explicitly mention the current or expected order book or pending orders. - However, strong demand momentum is highlighted across end-user applications, contributing to record quarterly sales. - The company indicates continued strong customer demand with utilization around 80% and potential to ramp up to full capacity. - New capacity expansions (Naidupeta debottlenecking and Dahej plant) are planned to meet increasing demand. - The company expects higher sales and volume growth to continue through FY27 and beyond. - Focus on product innovation and targeting new markets like ceramics, pharma, and specialty chemicals suggests a healthy and growing order pipeline. - Management emphasizes long-term confident outlook supported by strong customer relationships and continuous supply of raw materials. No specific quantitative data on order book or pending orders was provided in the transcript.

Capex plans

Yes
  • →A new greenfield plant in Dahej, Gujarat, with Phase 1 capacity of 15,000 to 18,000 tons per annum, expected to be commissioned by November 2026 (Q3 FY27).
  • →Ramp-up plan for Dahej plant: 50%-60% utilization in FY28, aiming for 70%-80% in FY29, followed by Phase 2 expansion.
  • →Dahej plant's revenue potential: INR 300-400 crores with EBITDA margins expected at 11%-12%.
  • →Capex payback target: 3 to 4 years with expected ROCE in the mid-20% range.
  • →Naidupeta plant is undergoing debottlenecking to add about 5,000 tons capacity; capex details to be confirmed.
  • →The company is strengthening R&D and focusing on high-value specialized products, including rubber recycling and niche chemical products.
  • →Continued strategic emphasis on expanding non-rubber applications through the Dahej facility and new product development.

How does J.G.Chemicals rank vs peers in Chemicals & Petrochemicals?

Pro feature
1J.G.Chemicals
Rev 3Mar 2
2Chemicals & Petrochemicals Company A
Rev 1Mar 2
3Chemicals & Petrochemicals Company B
Rev 2Mar 1
4Chemicals & Petrochemicals Company C
Rev 2Mar 3

See full Chemicals & Petrochemicals sector rankings

How does J.G.Chemicals rank in Chemicals & Petrochemicals?

Compare J.G.Chemicals against every Chemicals & Petrochemicals company (Q1 FY27) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Related research

Read the full Q1 FY27 earnings insight — J.G.Chemicals

Other quarters — J.G.Chemicals

Q4 FY26Q3 FY26Q2 FY26Q1 FY26

Chemicals & Petrochemicals peers

Aarti Industries · Q1 FY27BASF India · Q4 FY26Deepak Fertilis. · Q1 FY27Deepak Nitrite · Q1 FY27Himadri Special · Q1 FY27
J.G.Chemicals full stock analysisChemicals & Petrochemicals sectorEarnings call directoryRankings dashboard

Questions about this analysis? Chat directly with the founder — real answers about the research, not a support bot.

WhatsApp the founder

Research team or advisory firm? Get earnings-call intelligence and ranking history as research inputs for your firm.

For Institutions

Arthneeti AI

AI-powered stock analysis from earnings call transcripts. Helping Indian investors make smarter decisions with data-driven insights.

Analysis

  • Stock Rankings
  • Sectors
  • Compare Stocks
  • IPO Dashboard
  • Stock Screener
  • Earnings Call Analysis
  • Stocks Under ₹500
  • Multibaggers

Tools

  • MF Overlap Checker
  • SIP Calculator
  • CAGR Calculator
  • FD vs Equity
  • All Calculators

Resources

  • Blog
  • Weekly Digest
  • Portfolio Analysis
  • Build Portfolio
  • Earnings Calendar
  • Q1 FY27 Earnings Hub

Company

  • Pricing
  • How Our Analysis Works
  • For Institutions
  • Terms of Service
  • Privacy Policy

Compare

  • vs Screener.in
  • vs Trendlyne
  • vs Tickertape
  • vs Moneycontrol Pro
+91 90841 32575 support@arthneeti.com Bengaluru, India

© 2026 Arthneeti AI. All rights reserved.

AI-analyzed data from 1,500+ company earnings calls

Continue your research

What J.G.Chemicals's management said in earlier quarters

  • Q1 FY27 earnings call analysis →
  • Q3 FY26 earnings call analysis →
  • Q1 FY26 earnings call analysis →
  • Q4 FY26 earnings call analysis →

Others in Chemicals & Petrochemicals this season

  • Indo Borax & Chemicals Ltd (Q4 FY26)

    175 crores revenue in the previous financial year and Rs. Key concall takeaways from Indo Borax & Chemicals Ltd's Q4 FY26 earnings call — and how it ranks…

  • Fineotex Chemical Ltd (Q1 FY27)

    INR 1,000 crores in FY'26. Key concall takeaways from Fineotex Chemical Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.

  • Tanfac Inds. (Q1 FY27)

    Around 80% to 85% of the solar grade DHF plant capacity is contracted. Key concall takeaways from Tanfac Inds.'s Q1 FY27 earnings call — and how it ranks…

  • Epigral (Q1 FY27)

    Profit after tax (PAT) grew 25% in Q1 FY27 compared to Q1 FY26, reflecting resilience despite a challenging environment. Key concall takeaways from Epigral's…

Compare:vs Solar Industries India Ltdvs Pidilite Inds.vs SRF